Photodynamic Therapy Can Modulate the Nasopharyngeal Carcinoma Microenvironment Infected with the Epstein-Barr Virus: A Systematic Review and Meta-Analysis
- PMID: 37239013
- PMCID: PMC10216108
- DOI: 10.3390/biomedicines11051344
Photodynamic Therapy Can Modulate the Nasopharyngeal Carcinoma Microenvironment Infected with the Epstein-Barr Virus: A Systematic Review and Meta-Analysis
Abstract
Nasopharyngeal carcinoma is a malignancy from epithelial cells predominantly associated with the Epstein-Barr virus (EBV) infection, and it is responsible for 140,000 deaths annually. There is a current need to develop new strategies to increase the efficacy of antineoplastic treatment and reduce side effects. Thus, the present study aimed to perform a systematic review and meta-analysis of the ability of photodynamic therapy (PDT) to modulate the tumor microenvironment and PDT efficacy in nasopharyngeal carcinoma treatment. The reviewers conducted all steps in the systematic review. PubMed, Science Direct, Scopus, Scielo, Lilacs, EMBASE, and the Cochrane library databases were searched. The OHAT was used to assess the risk of bias. Meta-analysis was performed with a random-effects model (α = 0.05). Nasopharyngeal carcinoma cells treated with PDT showed that IL-8, IL-1α, IL-1β, LC3BI, LC3BII, MMP2, and MMP9 levels were significantly higher than in groups that did not receive PDT. NF-ĸB, miR BART 1-5p, BART 16, and BART 17-5p levels were significantly lower in the PDT group than in the control group. Apoptosis levels and the viability of nasopharyngeal carcinoma cells (>70%) infected with EBV were effective after PDT. This treatment also increased LMP1 levels (0.28-0.50/p < 0.05) compared to the control group. PDT showed promising results for efficacy in killing nasopharyngeal carcinoma cells infected with EBV and modulating the tumor microenvironment. Further preclinical studies should be performed to validate these results.
Keywords: Epstein–Barr virus; meta-analysis; nasopharyngeal carcinoma; photodynamic therapy; systematic review.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.J Virol. 2016 Jun 24;90(14):6475-88. doi: 10.1128/JVI.00613-16. Print 2016 Jul 15. J Virol. 2016. PMID: 27147748 Free PMC article.
-
FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.J Photochem Photobiol B. 2013 Oct 5;127:114-22. doi: 10.1016/j.jphotobiol.2013.07.020. Epub 2013 Aug 6. J Photochem Photobiol B. 2013. PMID: 24013466
-
SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.Oncol Rep. 2015 Jun;33(6):2779-88. doi: 10.3892/or.2015.3913. Epub 2015 Apr 17. Oncol Rep. 2015. PMID: 25891128
-
Prevalence of Epstein-Barr virus infection in individuals with nasopharyngeal carcinoma in Malaysia: The first systematic review and meta-analysi.Trop Biomed. 2022 Mar 1;39(1):89-98. doi: 10.47665/tb.39.1.008. Trop Biomed. 2022. PMID: 35507931
-
Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis.PLoS One. 2022 Apr 18;17(4):e0266893. doi: 10.1371/journal.pone.0266893. eCollection 2022. PLoS One. 2022. PMID: 35436288 Free PMC article.
References
-
- Orlandi E., Iacovelli N.A., Tombolini V., Rancati T., Polimeni A., De Cecco L., Valdagni R., De Felice F. Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer. Oral Oncol. 2019;99:104453. doi: 10.1016/j.oraloncology.2019.104453. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous